REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/04/2026
Back to search
Official data from USPTO
SERVA HEALTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SERVA HEALTH
ST13
US500000087864722Class
35, 36, 42, 44, 45
Filing
87864722
Registration
6341949
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
05/05/2026
Trademark type
Word
Nice classes
35, 36, 42, 44, 45
Filing date
04/05/2018
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/06/2017
First use in commerce
11/06/2017
Drawing code
4
Owner type
16
Owner location
Mount Laurel, NJ, US
Examiner
MARTIN, CHRISTINE C
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SERVA HEALTH LLC
Representatives
John J. O'Malley VOLPE AND KOENIG PC
Technical classification
Nice Classes
Class 35Class 36Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical and/or medical device cost management for the healthcare benefit plans of others; Healthcare utilization and review services as they relate to prescription drugspharmaceutical and/or medical device cost managementdrug utilization review servicesBusiness administration of pharmacy reimbursement programs and servicesBusiness administration of patient reimbursement programs; Business consultation in the field of healthcarepharmaceuticalshospital pharmacyspecialty pharmacymedical devices; Cost management for the healthcarepharmacyprescription drug benefit plans of others; Specialty pharmacy servicesdata collection services in the nature of patient information intake to maintain and retain patients on medication and report data for business purposes; Compiling of information into computer databases; Patient relationship management services; Business management in the field of patient assistance programsprescription drugsnew specialty drugs; Management of telephone call centers for others; Operation of telephone call centers for others; Management and operation of telephone call centers for specialty pharmaceutical companies; Business consulting services for specialty pharmaceutical companies; Product complaint processing services for drugs and medical devicescollection of complaint information from patients of adverse events and medical reactions to drugs or medical devices into computer databases and reporting data to drug or medical device manufacturer for business purposes; Customer servicesresponding to inquiries from and reaching out to patients for others with respect to drugs and medical devices they are utilizing; Customer servicesresponding to inquiries from and reaching out vendors providing clinical studies for others with respect to drugs and medical devices they are studying; Administrative processing of invoices; clinical research selection servicesselection and identification of clinical investigators and researchers for clinical studies; Recruiting and enrolling patients for clinical studies; Recruiting and enrolling clinical investigators and researchers to conduct clinical studies for clinical studies
Class 36
Financial administration of patient reimbursement programs; Pharmaceutical and/or medical device benefit management services; Providing information in the field of health benefit plansproviding benefits pre-screening services in the nature of providing health benefit information for clinical trialspharmaceutical treatmentmedical devicessurgical procedures; Healthcare benefits investigationproviding consultation in the field of healthcare benefits; Healthcare and pharmaceutical benefits verificationinsurance eligibility verification; Healthcare and pharmaceutical prior authorization servicesinsurance eligibility review; Healthcare review services as they relate to prescription drugsinsurance eligibility review and verification; Providing information about drug reimbursement for prescriberspatientsthe pharmaceutical industry by means of a call center; Claims administration services in the field of health insuranceadministration of healthcare assignment of benefits for others and verification of patient eligibility for health- and prescription-benefits coverage of pharmaceuticals
Class 42
Compiling data for research purposes in the field of medical science and medical consultancy; Data warehousing; Providing temporary use of online non-downloadable software for use in health information systems for receivingprocessingtransmittingdisplaying datacontrolling and managing patient health informationmedical and healthcare analytics; Providing temporary use of online non-downloadable software for use in hub servicespatient support servicespharmacy benefits investigationmedication ordersco-pay assistancebilling and account receivablesshipping and reportingpatient data aggregation and analysiscall center servicesplacing and tracking prescription medication orderstracking and analyzing patient clinical care outcomes; Providing temporary use of online non-downloadable software for use in customer relationship management (CRM); Providing temporary use of online non-downloadable software for providing call and contact center functions; Providing online computer databases and online searchable databases featuring medical and scientific research information in the field of clinical trials
Class 44
Pharmaceutical consultation in the field of new specialty drugs; Providing information to patients in the field of administering medications; Providing medical information to patients; Patient healthcare counseling and advice regarding products in the field of prescription drugs; Providing medical information in the field of adherence and compliance to prescribed medication dosing regimens and disease state for prescriberspatientsthe pharmaceutical and/or medical device industry by means of a call center; Collecting and reporting medical information about drugs or medical devicesproviding medical information about drug interaction and medical device interaction by means of call centersproviding medical information regarding adverse events regarding drugs and medical devicesproviding medical information about drugs and medical devices requested by medical providers; Direct response medical pre-screening services for clinical trialspharmaceutical treatmentmedical devicessurgical procedures; Reviewingabstractingprocessinganalyzing data from patient medical chartsproviding medical profiles and medical record analysis and assessments for medical purposes
Class 45
Providing case management and clinical servicescoordinating legalmedicalphysicalsocialpersonal carepsychological services for childrenadultselderly individuals; Providing patient advocate and case management servicescoordinating the procurement and administration of medication; providing clinical research case management servicescoordination of medical services for others involving drugs and medical devices
Publications
History of USPTO decisions and trademark events.
47 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/30/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/29/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/04/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/01/2021
IUAF
USE AMENDMENT FILED
02/09/2021
EISU
TEAS STATEMENT OF USE RECEIVED
02/09/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2020
PUBO
PUBLISHED FOR OPPOSITION
06/16/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2020
ALIE
ASSIGNED TO LIE
05/12/2020
EXPT
EXPARTE APPEAL TERMINATED
05/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/08/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/08/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/08/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/14/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/14/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/14/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/14/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/25/2019
GNRT
NON-FINAL ACTION E-MAILED
10/25/2019
CNRT
NON-FINAL ACTION WRITTEN
10/25/2019
EXPI
EX PARTE APPEAL-INSTITUTED
09/23/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
09/23/2019
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
09/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/04/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/04/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/21/2019
GNFR
FINAL REFUSAL E-MAILED
03/21/2019
CNFR
FINAL REFUSAL WRITTEN
03/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/28/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/27/2018
GNRT
NON-FINAL ACTION E-MAILED
07/27/2018
CNRT
NON-FINAL ACTION WRITTEN
07/27/2018
DOCK
ASSIGNED TO EXAMINER
07/20/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2018
NWAP
NEW APPLICATION ENTERED
04/09/2018
Continuous trademark protection
Get notified about every new filing that threatens SERVA HEALTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.